Pharma Privat GmbH
Pharma Privat GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 2005, the company has established itself as a leader in the development and distribution of high-quality generic medications and innovative healthcare solutions. With a focus on prescription drugs, over-the-counter products, and specialised therapies, Pharma Privat GmbH is committed to enhancing patient care through its unique offerings. The company’s dedication to quality and compliance has earned it a strong market position, recognised for its reliability and efficiency in the supply chain. Notable achievements include strategic partnerships and a robust portfolio that caters to diverse therapeutic areas, ensuring that Pharma Privat GmbH remains at the forefront of the pharmaceutical landscape.
DitchCarbon Score
How does Pharma Privat GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharma Privat GmbH's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharma Privat GmbH's reported carbon emissions
Pharma Privat GmbH, headquartered in Germany, currently does not report any carbon emissions data, as indicated by the absence of specific figures for the most recent year. Consequently, there are no recorded emissions in terms of Scope 1, 2, or 3. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there is no available data on emissions or reduction initiatives, it is essential to note that Pharma Privat GmbH may still be in the early stages of developing its climate strategy. In the broader context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon neutrality, often setting ambitious targets in line with global climate agreements. However, without specific commitments or data, it remains unclear how Pharma Privat GmbH plans to engage with these industry trends.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharma Privat GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
